Alzheimer’s Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis
Open Access
- 7 November 2017
- journal article
- review article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 60 (4) , 1223-1229
Abstract
The decreased availability of metabolizable energy resources in the central nervous system is hypothesized to be a key factor in the pathogenesis of Alzheimer’s disease. More specifically, the age-related decline in the ability of glucose to cross thKeywords
This publication has 75 references indexed in Scilit:
- Alzheimer's disease as homeostatic responses to age-related myelin breakdownNeurobiology of Aging, 2011
- Apolipoprotein E in Alzheimer's disease and other neurological disordersThe Lancet Neurology, 2011
- An Overview of APP Processing Enzymes and ProductsNeuroMolecular Medicine, 2009
- Awake Intranasal Insulin Delivery Modifies Protein Complexes and Alters Memory, Anxiety, and Olfactory BehaviorsJournal of Neuroscience, 2009
- Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trialNutrition & Metabolism, 2009
- Therapeutics for Alzheimer's Disease Based on the Metal HypothesisNeurotherapeutics, 2008
- Protective effects of NSAIDs on the development of Alzheimer diseaseNeurology, 2008
- PPARs in Alzheimer′s DiseasePPAR Research, 2008
- Supply and Demand in Cerebral Energy Metabolism: The Role of Nutrient TransportersJournal of Cerebral Blood Flow & Metabolism, 2007
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005